Oral Answers to Questions

Rachael Maskell Excerpts

Tuesday 19th January 2021 Commons Chamber

[Bell Ribeiro-Addy (Streatham) (Lab)]

What recent steps the Government have taken to help ensure equitable access to covid-19 vaccines for people living in the global south.

[Rachael Maskell (York Central) (Lab/Co-op)]

What recent steps the Government have taken to help ensure equitable access to covid-19 vaccines for people living in the global south.

[Dr Jamie Wallis (Bridgend) (Con)]

What diplomatic steps the Government are taking to support the development and distribution of covid-19 vaccines (a) in the UK and (b) throughout the world.

--- Later in debate ---

[Wendy Morton]

When it comes to vaccines, we have been very clear that we support equitable access. This is a global pandemic. This is a virus that respects no boundaries and no barriers. That is why we are working and leading the way at the forefront of multilateral efforts to ensure we get equitable access through this really important COVAX facility.

[Rachael Maskell [V]]

I want to press the Minister further, because none of us is safe until all of us are safe. Clearly, with the threat of the spread and the mutation of the virus we are all at risk until the world is vaccinated. Will the Minister say specifically what work her Government have done to overcome intellectual property rights to ensure the manufacture of the vaccine in the global south and ensure that those countries that currently cannot get access to the vaccine can distribute it locally?

[Wendy Morton]

The UK believes that a robust and fair intellectual property system is a key part of the innovation framework that allows economies to grow and become innovators, while enabling society to benefit from knowledge and ideas. We believe that non-exclusive voluntary licensing has advantages over compulsory licensing, because it creates a sounder basis for long lasting beneficial relationships and incentives to create and commercialise new inventions such as those life-changing vaccines.